Wednesday, May 01, 2013
   
TEXT_SIZE

MYMX Stock Price

    This link will direct you to Mymetics' quoted Stock Price on NASDAQ's website.

 

SEC Filings

pdfmymx_10k_december31_2012           
pdfmymx_10q_sept30_2012                  10q_2012_septembre_XBRL

 

SEC Insiders' "Section 16" Filings

This Link Will Direct You To Mymetic's Insider Filings on the SEC website.

Key Statistics (as of 13-Sep-2012)

Symbol MYMX
Exchange OTCBB
Shares Outstanding 259M
Market Cap (approx.) 12M USD
52-week Hi-Lo ($) 0.17 - 0.01
Ave. Trading Vol (approx.) 65'000 shares
Fiscal year-end december 31

Standard & Poor's Research

This link will direct you to Standard & Poor's Market Access coverage of Mymetics.

Management

Ronald Kempers
President & Chief Executive Officer

    

Dr. Sylvain Fleury, PhD
Chief Scientific Officer

      


 


Forward-Looking Statements

This web site contains forward-looking statements that involve risks and uncertainties. The statements contained in this site that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These forward looking statements concern matters that involve risks and uncertainties that could cause actual results to differ materially from those stated in the forward-looking statements. Words such as "may," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential", "continue", "possibly" or "clearly" or similar words are intended to identify forward looking statements, although not all forward looking statements contain these words.
Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity performance or achievements, nor can we guarantee that our prototype vaccines will be proved effective under human clinical trials conditions. Moreover, neither we nor any other person assume responsibility for the accuracy and completeness of the forward-looking statements. We are under no duty to update any of the forward-looking statements after they have been disclosed, or to ensure such statements conform to actual results or to changes in our expectations.
Readers are urged to carefully review and consider the various disclosures made by us which attempt to advise interested parties of the factors which affect our business, including without limitation disclosures made under the captions "Management Discussion and Analysis of Financial Condition and Results of Operations," "Risk Factors," "Consolidated Financial Statements" and "Notes to Consolidated Financial Statements" included in the Company's annual report on Form 10-K for the year ended December 31, 2011 and in our Registration Statement on Form S-1 dated May 22, 2002, as amended.

Standard&Poors - Analysis Report

To see the latest S&P report on Mymetics, click here: